Table 3 Analytical accuracy of BEAMing; Plasma vs Plasma and Tissue vs Tissue

From: A multicentre, prospective study of plasma circulating tumour DNA test for detecting RAS mutation in patients with metastatic colorectal cancer

  

Tissue-RASKET

Total

Concordance% [95% CI]

MT

WT

Tissue-BEAMing

MT

137

11

148

93.9 [90.5–96.3]

WT

7

139

146

Total

 

144

150

294

  

Plasma-NGS

Total

Concordance% [95% CI]

  

MT

WT

Plasma-BEAMing

MT

48

3

51

96.0 [90.1–98.9]

WT

1

48

49

Total

 

49

51

100

  1. MT Mutant, WT Wildtype
Back to article page